Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2004, Vol. 2 ›› Issue (6): 421-425.doi: 10.3736/jcim20040605

• Original Clinical Research • Previous Articles     Next Articles

Clinical study on idiopathic thrombocytopenic purpura treated with Shengxueling Granule

Yong-ming Zhou1, Ming-hui Hu1, Jing-ming Yang2, Wen-wei Zhu1, Zhen-qiao Huang1, Shao-hong Zhou1, Yi Xu1, Jia-hui Lu1#br#   

  1. 1. Department of Hematology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
    2. Department of Hematology, Xinhua Hospital, Shanghai Second Medical University, Shanghai 200092, China
  • Received:2004-07-01 Online:2004-11-20 Published:2018-10-20

Objective: To observe the clinical effect of Shengxueling Granule (SXLG) in treating idiopathic thrombocytopenic purpura (ITP), and to study its possible mechanism.Methods: Eighty-six cases of ITP were divided into two groups randomly. Fifty-six cases in the treatment group were treated with SXLG, a traditional Chinese medicine, and 30 cases administered with Western medicine (prednisone) were taken as control. Patients in each group took drugs for three months and were under follow-up observation.Results: In SXLG-treated group, the total effective rate in 3 months was 85.71%, similar to 83.33% in prednisone-treated group (P>0.05), while the total effective rate in 6 months in the SXLG-treated group was 91.07%, higher than 53.33% of the prednisone-treated group (P<0.01), and no obvious side-effects were observed. The patients’ bleeding was alleviated or stopped, and their general condition was improved. And the blood platelet count (BPC) was increased, the platelet associated immunoglobulin (PAIg) and interleukin-4 (IL-4) were markedly dropped, the level of natural killer cells activity (NKCA) increased, and the rate of T lymphocyte subsets gradually returned to normal level. Megakaryocytes tended toward maturation on bone marrow smear after SXLG treatment. All differences above were statistically significant.Conclusion: SXLG is an effective and safe medicine for ITP. It can regulate the cellular immunity, inhibit the platelet antibody to reduce the destruction of the platelet and to increase the number of platelet, promote the differentiation and maturation of megakaryocyte, facilitate the production and release of platelet, lower the fragility of capillary, and prevent the hemorrhagic tendency.

Key words: Shengxueling Granule, purpura, thrombocytopenic, idiopathic, traditional Chinese medical therapy

CLC Number: 

  • R289.5


Group n Grading of hemorrhage
SXLG-treated group
Before treatment 56 6 14 34 2
After treatment 30 19 6 5 0
Pednisone-treated group
Before treatment 30 3 8 18 1
After treatment 13 8 3 2 0

Tab 2

Comparison of therapeutic effects between SXLG- and pednisone-treated groupsCases (%)"

Group n Significantly
Improved Ineffective Total effective rate
SXLG-treated group
After 3 months treatment 56 9(16.07) 17(30.36) 22(39.29) 8(14.28) 48(85.71)
After 6 months treatment 56 17(30.36) 25(44.64) 9(16.07) 5(8.93) 51(91.07)**
Pednisone-treated group
After 3 months treatment 30 3(10.00) 12(40.00) 10(33.33) 5(16.67) 25(83.33)
After 6 months treatment 30 1(3.33) 6(20.00) 9(30.00) 14(46.67) 16(53.33)


SXLG-treated group
Before treatment 56 73.67±45.50 12.74±10.26 11.16±7.48
After treatment 56 33.20±24.68△△ 7.08±5.92△△ 7.68±5.86△△
Pednisone-treated group
Before treatment 30 71.63±43.73 11.96±9.78 10.90±6.65
After treatment 30 29.14±23.65△△ 6.02±3.69△△ 6.32±3.75△△

Tab 4

Changes of NKCA and IL-4 before and after SXLG treatment ($\bar{x}$±s )"

Group n NKCA (%) IL-4 (kU/L)
SXLG-treated group
Before treatment 36 13.26±6.28 74.16±15.48
After treatment 36 17.49±5.96△△ 63.22±12.36△△
Normal control group 20 20.30±6.50 58.65±6.68

Tab 5

Changes of T lymphocyte subsets before and after SXLG treatment ($\bar{x}$±s )"

Group n CD+3(%) CD+4(%) CD+8(%) CD+4/CD+8
SXLG-treated group
Before treatment 30 52.63±8.66▲▲ 36.64±5.06▲▲ 27.84±5.20 1.32±0.26▲▲
After treatment 30 62.14±9.10△△▲ 41.26±6.82△△ 22.98±4.82△△ 1.79±0.32△△
Normal control group 20 68.20±10.07 43.72±6.12 24.65±5.32 1.81±0.25

Tab 6

Changes of bone marrow megakaryocytes before and after SXLG treatment ($\bar{x}$±s, %)"

Time n Megakaryoblast and
Before treatment 36 14.66±9.82 69.68±12.18 4.26±3.04 11.40±8.06
After treatment 36 20.02±10.08 59.79±13.36△△ 10.94±8.76△△ 9.25±6.69
[1] 张之南, 沈悌 . 血液病诊断及疗效标准(第2版)[M]. 北京: 科学出版社, 1999,( 第2版):279-282
[2] 陈丙莺, 马建吟, 黄钦田 , 等. 简易自然杀伤试验—LDH释放改良法[J]. 上海免疫学杂志, 1989,9(4):218-219
[3] 全国中医学会内科学会. 特发性血小板减少性紫癜出血程度分级标准[S]. 北京中医学院学报, 1984,7(4):25-27.
[4] Viganaux F, Golstein P . Fas-based lymphocyte-mediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway[J]. Eur J Immunol, 1994,24(4):923-927
doi: 10.1002/(ISSN)1521-4141
[5] McFarland J . Pathophysiologyof platelet destruction in immune(idiopathic) thrombocytopenic purpura[J]. Blood Rev, 2002,16(1):1-2
doi: 10.1054/blre.2001.0169
[1] Xue-qing Yu, Shu-guang Yang, Yang Xie, Jian-sheng Li. Traditional Chinese medicine in the treatment of idiopathic pulmonary fibrosis based on syndrome differentiation: Study protocol of exploratory trial. Journal of Integrative Medicine, 2020, 18(2): 163-168.
[2] Hui-hua Zhu, Yan-ping Chen, Jian-er Yu, Min Wu, Zhan Li. Therapeutic effect of Xincang Decoction on chronic airway inflammation in children with bronchial asthma in remission stage. Journal of Chinese Integrative Medicine, 2005, 3(1): 23-27.
[3] Xiao-yi Zhang, Cheng-bao Kuang. Clinical observation on treatment of nonalcoholic fatty liver disease complicating hyperuricemia by Zhifang Ⅰ Decoction. Journal of Chinese Integrative Medicine, 2004, 2(4): 265-267.
Full text



[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022